The American Society for Transplantation and Cellular Therapy (ASTCT) has chosen Miguel-Angel Perales, MD, as President of the Society in 2023–2024. Dr. Perales first served on the Board of Directors in 2017 and has been a member of ASTCT since 2001. He is Chief of the Adult Bone Marrow Transplantation Service at Memorial Sloan Kettering Cancer Center, New York, and Professor of Medicine at Weill Cornell Medical College.
“I have enjoyed serving on the ASTCT Board of Directors, and I am honored to serve as President this year,” stated Dr. Perales. “In my practice, my patients have a variety of hematologic malignancies and are in need of an allogeneic transplant or cellular therapy. The goal of my practice, research, and now as President of ASTCT is to further advocate for our patients and support our field by advancing the science and further providing educational opportunities for our members.”
Miguel-Angel Perales, MD
A Leader in Research and Education
Prior to his time on the ASTCT Board of Directors, Dr. Perales served on the Society’s Education Committee as well as the Committee for Practice Guidelines, and he is the founding editor of the ASTCT mobile app. As ASTCT President, Dr. Perales will direct the organization’s new strategic plan and continue to bring more science focus to ASTCT to help advance better treatment options for patients.
Dr. Perales is the current Chair of the Alliance for Clinical Trials in Oncology Transplantation and Cell-Based Therapies Committee and has served as Vice-Chair and member of the Board of Directors of the Be The Match registry (operated by the National Marrow Donor Program). He has also held leadership positions in the Center for International Blood and Marrow Transplant Research and Blood and Marrow Transplantation Clinical Trials Network.
Professionally, Dr. Perales is an expert in donor-derived hematopoietic stem cell transplantation and cellular therapy. He is currently participating in several studies designed to improve outcomes in patients undergoing stem cell transplantation, including looking at ways to lower the risk of complications, relapse, and graft-vs-host disease. He is also conducting translational clinical research to investigate new ways to enhance the recovery of the immune system after transplantation and ways to help the immune system fight hematologic malignancies. Dr. Perales’ work has appeared in more than 350 publications, including peer-reviewed articles, position papers, guidelines, editorials, invited reviews, and book chapters.
